B-1 cells promote immunosurveillance against murine melanoma in host absence of CCR5: New perspective in autologous vaccination therapy

Immunobiology

Volumn 219, Issue 11, 2014, Pages 845-849

  Vivanco, Bruno C ^a   Viana, Jacqueline D ^a   Perez, Elisabeth C ^b   Konno, Fabiana T C ^b   Guereschi, Marcia G ^a   Xander, Patricia ^a   Keller, Alexandre C ^a   Lopes, José D ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b PAULISTA UNIVERSITY   (Brazil)

Author keywords

Autologous vaccination; B 1 lymphocytes; B16F10 melanoma; CCR5; Tumor

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; MELANOMA VACCINE; SODIUM CHLORIDE; CANCER VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B 1 LYMPHOCYTE; B LYMPHOCYTE; B16F10 CELL LINE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER PREVENTION; CANCER RESISTANCE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNOSURVEILLANCE; INOCULATION; LUNG METASTASIS; LYMPHOCYTE MIGRATION; MALE; MELANOMA; MELANOMA CELL LINE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PERITONEUM CELL; PROTEIN DEPLETION; T LYMPHOCYTE ACTIVATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; CELL MOTION; DEFICIENCY; GENETICS; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; KNOCKOUT MOUSE; MELANOMA, EXPERIMENTAL; METABOLISM; MORTALITY; PATHOLOGY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL LINE;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTE SUBSETS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL MOVEMENT; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MONITORING, IMMUNOLOGIC; RECEPTORS, CCR5;

EID: 84908231282     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.07.013     Document Type: Article

References (14)

1. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 2011, 11:34.
2. Chang L.Y., Lin Y.C., Mahalingam J., Huang C.T., Chen T.W., Kang C.W., Peng H.M., Chu Y.Y., Chiang J.M., Dutta A., Day Y.J., Chen T.C., Yeh C.T., Lin C.Y. Tumor-derived chemokine CCL5 enhances TGF-beta-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res. 2012, 72:1092.
3. Dannenmann S.R., Thielicke J., Stockli M., Matter C., von Boehmer L., Cecconi V., Hermanns T., Hefermehl L., Schraml P., Moch H., Knuth A., van den Broek M. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. Oncoimmunology 2013, 2:e23562.
4. Feldman, J.G., R. Mark, S., Schwartz, J., Orion, I., 2009. A mathematical model for tumor volume evaluation using two-dimensions. J. Appl. Quantit. Methods 4.
5. Hussein M.R. Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity. Int. J. Exp. Pathol. 2006, 87:163.
6. Labrousse A.L., Ntayi C., Hornebeck W., Bernard P. Stromal reaction in cutaneous melanoma. Crit. Rev. Oncol. Hematol. 2004, 49:269.
7. Lee N.J., Choi D.Y., Song J.K., Jung Y.Y., Kim D.H., Kim T.M., Kim D.J., Kwon S.M., Kim K.B., Choi K.E., Moon D.C., Kim Y., Han S.B., Hong J.T. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model. Carcinogenesis 2012, 33:2520.
8. Mrowietz U., Schwenk U., Maune S., Bartels J., Kupper M., Fichtner I., Schroder J.M., Schadendorf D. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Brit. J. Cancer 1999, 79:1025.
9. Ng-Cashin J., Kuhns J.J., Burkett S.E., Powderly J.D., Craven R.R., van Deventer H.W., Kirby S.L., Serody J.S. Host absence of CCR5 potentiates dendritic cell vaccination. J. Immunol. 2003, 170:4201.
10. Perez E.C., Machado J., Aliperti F., Freymueller E., Mariano M., Lopes J.D. B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway. Cancer Sci. 2008, 99:920.
11. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 2009, 86:1065.
12. Song J.K., Park M.H., Choi D.Y., Yoo H.S., Han S.B., Yoon do Y., Hong J.T. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and upregulation of IL-1Ra in melanoma model. PLoS One 2012, 7:e33747.
13. Sindhava V., Woodman M.E., Stevenson B., Bondada S. Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS One 2010, 5:e11445.
14. Xander P., Brito R.R., Perez E.C., Pozzibon J.M., de Souza C.F., Pellegrino R., Bernardo V., Jasiulionis M.G., Mariano M., Lopes J.D. Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression. Immunobiology 2013, 128:1293.